A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Public ClinicalTrials.gov record NCT07558668. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-part, FiH Study in Healthy Participants and Participants With Atopic Dermatitis (AD) to Assess the Safety, Tolerability, Pharmacokinetics (PK) of Single & Multiple Ascending Doses and Selected Dose of SYX-5219 (AD Participants).
Study identification
- NCT ID
- NCT07558668
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Sitryx Therapeutics Ltd
- Industry
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Interventions
- SYX-5219 Oral Capsule Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2025
- Primary completion
- Aug 29, 2026
- Completion
- Sep 29, 2026
- Last update posted
- Apr 29, 2026
2025 – 2026
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sitryx Clinical Site | Arkansas City | Arkansas | 72117 | Recruiting |
| Sitryx Clinical Site | Fremont | California | 94538 | Recruiting |
| Sitryx Clinical Site | Plainfield | Indiana | 46168 | Recruiting |
| Sitryx Clinical Site | Boardman | Ohio | 44512 | Recruiting |
| Sitryx Clinical Site | Philadelphia | Pennsylvania | 19103 | Recruiting |
| Sitryx Clinical Site | Bountiful | Utah | 84010 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07558668, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2026 · Synced May 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07558668 live on ClinicalTrials.gov.